The Effect of Stromal Vascular Fraction on Scar Formation of Transverse Rectus Abdominis Muscle Flap Donor Sites: A Pilot Study

다국어 초록 (Multilingual Abstract)

Background: Stromal vascular fraction (SVF), which plays a substantial role in wound healing, has been discussed in many recent studies concerning its positive effect on scar formation. Our study explored the effects of SVF on scar formation from partially-removed transverse rectus abdominis muscle (TRAM) flaps after inset.
Methods: From December 2017 to May 2020, we enrolled 11 patients undergoing breast reconstruction performed by a single surgeon using the free TRAM flap. As a split-body, placebo-controlled study, SVF was subcutaneously injected into one side of the abdomen, and normal saline was injected into the other side of each patient. Scarring was evaluated using the Vancouver Scar Scale (VSS) and Patient Scar Assessment Questionnaire (PSAQ) at 1, 6, and 12 months after surgery, and histology was evaluated with immunofluorescence analysis at 6 months after surgery.
Results: No statistically significant differences were noted in the total scores or subcategory score of the VSS and PSAQ between the test and control groups. Some patients showed more positive staining for alpha smooth muscle actin, collagen type I, and type III in the test group than in the control group. However, quantification of positively stained areas showed no statistically significant difference.
Conclusion: Intraoperative SVF injection had no demonstrable clinical effect on scar quality. Histology with immunofluorescence analysis also failed to demonstrate any significant effect of SVF on scars at the microscopic level. Despite previous studies indicating the positive effects of SVF on scar quality, this pilot study questions its true effectiveness.

참고문헌 (Reference)

1 Gu Z, "Use of condensed nanofat combined with fat grafts to treat atrophic scars" 20 : 128-135, 2018

2 Jan SN, "Unfiltered nanofat injections rejuvenate postburn scars of face" 82 : 28-33, 2019

3 Tran B, "Topical scar treatment products for wounds : a systematic review" 46 : 1564-1571, 2020

4 Chang H, "Safety of adipose-derived stem cells and collagenase in fat tissue preparation" 37 : 802-808, 2013

5 Moon KC, "Possibility of injecting adipose-derived stromal vascular fraction cells to accelerate microcirculation in ischemic diabetic feet : a pilot study" 12 : 107-113, 2019

6 Aronowitz JA, "Mechanical versus enzymatic isolation of stromal vascular fraction cells from adipose tissue" 4 : 713-, 2015

7 Nangole FW, "Keloid pathophysiology : fibroblast or inflammatory disorders?" 22 : 44-54, 2019

8 Markarian CF, "Isolation of adipose-derived stem cells : a comparison among different methods" 36 : 693-702, 2014

9 Robert S, "Involvement of matrix metalloproteinases(MMPs)and inflammasome pathway in molecular mechanisms of fibrosis" 36 : e00360-, 2016

10 Lau K, "Exploring the role of stem cells in cutaneous wound healing" 18 : 921-933, 2009

11 Niddam J, "DIEP flap for breast reconstruction : retrospective evaluation of patient satisfaction on abdominal results" 67 : 789-796, 2014

12 Gentile P, "Comparing different nanofat procedures on scars : role of the stromal vascular fraction and its clinical implications" 12 : 939-952, 2017

13 Tenna S, "Comparative study using autologous fat grafts plus platelet-rich plasma with or without fractional CO2 laser resurfacing in treatment of acne scars : analysis of outcomes and satisfaction with FACE-Q" 41 : 661-666, 2017

14 Lee JW, "Clinical impact of highly condensed stromal vascular fraction injection in surgical management of depressed and contracted scars" 42 : 1689-1698, 2018

15 Fang F, "Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling" 83 : 95-105, 2016

16 Bhooshan LS, "Autologous emulsified fat injection for rejuvenation of scars : a prospective observational study" 51 : 77-83, 2018

17 Li Y, "Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway" 7 : 102-, 2016